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Abstract
Background: Pregnant women are more susceptible to malaria, which is associated with serious
adverse effects on pregnancy. The presentation of malaria during pregnancy varies according to the
level of transmission in the area. Our study aimed to demonstrate the prevalence and risk factors
for malaria (age, parity and gestational age) among pregnant women of eastern Sudan, which is
characterized by unstable malaria transmission.
Methods:  The prevalence and possible risk factors for Plasmodium falciparum malaria were
investigated in 744 pregnant Sudanese women attending the antenatal clinic of New Haifa Teaching
Hospital, eastern Sudan, during October 2003-April 2004.
Results: A total 102 (13.7%) had P. falciparum malaria, 18(17.6%) of these were severe cases
(jaundice and severe anaemia). Univariate and multivariate analysis showed that, age and parity
were not associated with malaria. Women who attended the antenatal clinic in the third trimester
were at highest risk for malaria (OR = 1.58, 95% CI = 1.02–2.4; P < 0.05).
Women with malaria had significantly lower mean haemoglobin (9.4 g/dl, 95% CI 9.1–9.7 versus
10.7, CI 10.6–10.8, P < 0.05). A significantly lower haemoglobin was observed in those with severe
falciparum malaria compared to non-severe form (8.3 g/dl, 95% CI 7.6–9.1 versus 9.4, 95% CI 9.1–
9.7, P = < 0.05).
Conclusion:  The results suggest that P. falciparum malaria is common in pregnant women
attending antenatal care and that anaemia is an important complication. Preventive measures
(chemoprophylaxis and insecticide-treated bednets) may be beneficial in this area for all women
irrespective of age or parity.
Background
Pregnant women are more susceptible to malaria, which
causes serious adverse effects including abortion, low
birth weight and maternal anaemia. It is the leading cause
maternal mortality in Sudan [1-7].
The presentation of malaria during pregnancy varies
according to the pre-existing immunity of the mother.
Women living in areas of low transmission have little
immunity to malaria which can cause severe syndromes,
such as cerebral malaria and pulmonary oedema. In
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contrast, those who live in areas of stable malaria trans-
mission enjoy greater immunity and experience fewer
symptoms during episodes of malaria, although they
commonly develop severe anaemia as consequence of the
infection [1,2,5,8,9].
Understanding the epidemiology of malaria during preg-
nancy provides important insight into relevant immuno-
logical processes and facilitates decision on control
strategies. Although there are extensive studies in highly
endemic African countries [1,2,5,6,10-12], there is little
published data available for Sudan, an African country
where P. falciparum malaria transmission is unstable in
the eastern region [13]. The study was conducted to inves-
tigate the prevalence and associated risk factors for P. fal-
ciparum malaria in pregnant women from eastern Sudan.
Patients and methods
Data collection
Pregnant women attending antenatal clinic (booking
visit) of the New Haifa Teaching Hospital, eastern Sudan,
during the period October 2003-May 2004 were
approached to participate in the study. After verbal con-
sent, questionnaires were administered requesting demo-
graphic informations on age, parity, gestational age and
history of maternal illness. Gestational age was calculated
from the last menstrual period and confirmed by ultra-
sound, when clinically indicated. Physical examination
was completed to identify signs of severe malaria [14] and
also obstetrical examination (blood pressure, pallor, fun-
dal level and foetal heart sound).
Laboratory methods
Thick and thin blood films were prepared from capillary
blood, stained with Giemsa and 100 oil immersion fields
were examined. Parasite density was determined by
counting parasites and 200 leucocytes, assuming each
woman has 6,000 leucocytes/µl. All the slides were dou-
ble-checked blindly.
The haemoglobin concentration was estimated by the
haematic acid method [15] in the first two months and,
subsequently, using Haemocure haemoglobinometer
(HemCue AB, Angelhom, Sweden). Ferrous sulfate (200
mg/day) and folic acid tablets (0.25 mg/day) were
supplied.
Ethical clearance
The study received ethical clearance from the Research
Board of the Faculty of Medicine, University of Khartoum.
Statistical analysis
Data were entered in a computer using SPSS for windows.
Comparisons between means and percentages were done
by Students' t-test, ANOVA, X2 and Fisher's exact tests as
appropriate. P < 0.05 was regarded as significant. Multi-
variate logistic regression was performed with malaria as
the dependent variable, using age, parity and gestation as
independent variables. These variables were categorized
and used as follows: median age, ≤  25 years versus >25
years); gravidae as primigravidae, secundigravidae, multi-
gravidae (3–5)or grandmultigravidae >5; gestation as first
(< 14 weeks), second (14–28 weeks) and third (> 28
weeks) trimester.
Results
Malaria and pregnancy
A total of 744 pregnant women attended the antenatal
clinic of New Haifa Teaching Hospital during the study,
29.5% were primigravidae.
Table 1 summarizes patient characteristics for all sub-
groups. 102 (13.7%) of women were infected with P. fal-
ciparum, 18(17.6%) of these were severe cases (jaundice
and severe anaemia). Malaria prevalence and intensity
(parasite count) were not significantly different amongst
the different gravidity sub-groups (P > 0.05). The highest
prevalence (18.3%) occurred in grandmultigravidae and
the highest intensity (11,511 parasites/µl) was observed
in primigravidae (Table 1).
Mean (SD) age (26.2 ± 5.7 years versus 25.9 ± 5.3 years, P
> 0.05) and parity (2.4 ± 2.4 versus 2.1 ± 2.1, P > 0.05)
were not significantly different between infected and non-
infected women. Two of 18 (11.1%), 29 of 290 (10%)
and 71 of 436 (16.3%) women were infected in the first,
second and third trimester respectively (P = 0.05).
Factors associated with malaria infection
Univariate and multivariate analysis indicated that, age
and parity were not significantly associated with malaria
infection. The third trimester was significantly associated
with malaria infection (OR = 1.58, 95% CI = 1.02–2.4; P
< 0.05)(Table 2).
Malaria and haemoglobin
Mean haemoglobin was significantly lower in infected
women (9.4 g/dl, 95% CI 9.1–9.7versus 10.7, CI 10.6–
10.8, P < 0.05). A lower haemoglobin also occurred in
women with severe malaria (9.4 g/dl, 95% CI 9.1–
9.7versus 8.3, 95% CI 7.6–9.1 P < 0.05).
Discussion
This study investigated the morbidity pattern of P. falci-
parum malaria during pregnancy in an area of New Haifa,
which is characterized by unstable transmission [13]. The
malaria prevalence was 13.7% and 18 women (17.6%)
were severe cases. With the exception of the neighbouring
country Ethiopia [6], malaria prevalence was much lower
than in other African countries characterized by intenseMalaria Journal 2005, 4:18 http://www.malariajournal.com/content/4/1/18
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malaria transmission [10-12]. Several severe cases
occured. In areas of unstable transmission, pregnant
women are more susceptible to severe falciparum malaria
than their non-pregnant peers [16] and different manifes-
tations of severe falciparum malaria including cerebral
malaria have been reported among pregnant women of
central Sudan [17].
The study showed no significant association between
malaria and parity, which is also reported from other
areas and locations with intense malaria transmission
[10,12,18]. In areas where transmission is high and the
level of acquired pregnancy immunity against malaria is
expected to be significant, primigravidae will be more
affected [1,2,11].
In contrast to the previous observations [10-12], age was
not significantly associated with malaria in the present
study. Lander et al have also reported no significant asso-
ciation between malaria infection and maternal age [18].
Women who attended the antenatal clinic in the third tri-
mester had about a 1.5-fold higher risk of malaria parasi-
taemia. This is in line with some observations, although
several studies report the second and early third trimesters
as the time of peak prevalence [1,3,4,10-12]. Dicko et al
reported the first trimester as the main risk period [19].
The mean haemoglobin was significantly lower in women
with malaria infection and significantly lower in severe
cases. Reduction of haemoglobin has been reported in
areas of unstable transmission in Thailand and in Ethio-
pia, as well as in areas with stable transmission [3,6].
Regardless of transmission level and pre-pregnancy level
of malaria immunity, maternal anaemia remains the most
frequent consequence of malaria during pregnancy [4].
Table 1: Characteristics of pregnant women in the study subjects *
Characteristics Total Primi-gravidae Secundi-gravidae Multi-gravidae Grand-multigravidae P Value
N (744) N (220) N (131) N (322) N (71)
Age (years) 26.6(9.9) 21.2(2.9) 25.7(2.3) 28.2(3.8) 34.9 (3.2) < 0.001
Gestation (weeks) 27.7 (7.7) 27.3(8.09) 28.1(6.9) 27.6(7.6) 28.3(28.3) 0.18
Haemoglobin (g/dl) 10.5(1.4) 10.5(1.3) 10.3(1.6) 10.6(1.3) 10.3(1.2) 0.2
Malaria (total) 102(13.7) 32(14.5) 14(10.7) 43(13.4) 13(18.3) 0.4
Non severe 84(11.3) 28(12.7) 9(6.9) 34(10.6) 13 (18.3) 0.08
Severe 18(2.4) 4(1.8) 5(3.8) 9 (2.8) 0 0.3
Parasite count (parasites/µl) 6,586 (19,640.2) 11,511 (3,222) 6,817 (14,383) 3,504 (7,729) 4,497 (7,748) 0.4
*Data as mean (SD) or number (%) as appropriate
Table 2: Risk factor analysis
Univariate Multivariate
Variable OR 95% CI P OR 95% CI P
Age ≤  25 1.03 0.68–1.5 0.40 0.90 0.52–1.6 0.74
Parity
Primigravidae 1.10 0.70–1.7 0.60 0.76 0.32–1.8 0.55
Secundigravidae 0.72 0.39–1.3 0.20 0.50 0.21–1.4 0.22
Multigravidae 0.96 0.62–1.4 0.80 0.74 0.37–1.4 0.41
Grandmultigravidae 1.40 0.77–2.7 0.20 3.20 0.27–46.2 0.30
Gestational age
First trimester 0.61 0.27–1.3 0.15 0.51 0.22–1.1 0.11
Second Trimester 0.71 0.45–1.3 0.09 0.67 0.41–1.08 0.10
Third trimester 1.50 1.02–2.4 0.02 1.58 1.02–2.4 0.03
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Conclusion
The results suggest that prevalence of P. falciparum malaria
is considerable in pregnant women in this part of Sudan
and severe cases do occur. Preventive measures (chemo-
prophylaxis and insecticide-treated bednets) may be ben-
eficial in this area for all women irrespective of their age
or parity.
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